Guest guest Posted June 22, 1999 Report Share Posted June 22, 1999 FYI =================================== Wampole Laboratories Launches First Rapid Test for Lyme Disease CRANBURY, N.J.--(BUSINESS WIRE)--June 21, 1999--Wampole Laboratories, a division of -Wallace, Inc. (NYSE:CAR) today announced that the PreVue B. burgdorferi Antibody Detection Assay, the first rapid test for Lyme disease, is now available. The launch of the PreVue B. burgdorferi test comes at the peak of Lyme season, which for most endemic areas occurs in late spring and summer. The PreVue product is being sold to physician offices and clinical laboratories by Wampole Laboratories through a network of authorized distributors. The Wampole PreVue B. burgdorferi assay is a simple two-step rapid membrane test which provides visually-read color results using serum or whole blood samples, including fingerstick blood. The test can be used in physician offices and other point of care settings and provides results in 20 minutes, as opposed to standard laboratory tests, which can take up to a week. Using the Wampole PreVue assay, physicians will be able to make a probable diagnosis of Lyme disease while the patient is present, and make antibiotic treatment decisions immediately. The Wampole PreVue B. burgdorferi test utilizes unique recombinant antigens rather than the whole cell preparations used in current laboratory tests. Antigenic proteins developed by recombinant DNA techniques allow for greater accuracy than other methods. In clinical studies, the Wampole PreVue B. burgdorferi assay demonstrated excellent performance in comparison to Western Blot and ELISA test methods on a CDC Lyme Disease stratified panel (95.2% agreement for Wampole PreVue versus 78.6% for Western Blot and 85.7% for ELISA). Ms. Zych, Vice President of Marketing for Wampole Laboratories provided the following comment: " The market reaction to the PreVue B. burgdorferi test has been tremendous. Not only does the recombinant technology provide greater accuracy, the test's speed and simplicity allows it to be performed in the physician's office while the patient waits for the results. This not only allows for more rapid treatment decisions, which improves the patient's outcome, but it also reduces patient anxiety over waiting up to a week for test results. " Luft M.D., Chairman of the Department of Medicine at SUNY, Stony Brook, where the PreVue test's core technology was developed, added the following: " This technology will allow both a rapid and more specific diagnosis of Lyme disease. A rapid diagnosis will allow prompt initiation of appropriate therapy, which is probably the most important factor in curing this disease. " Lyme disease is the most common insect-borne infectious disease in North America and is a significant public health concern. Spread to humans primarily by tick bite, its causative agent is the spirochete Borrelia burgdorferi. Clinical manifestations of Lyme disease include a large bulls-eye rash, followed by flu-like symptoms, fatigue and joint pain. Diagnosis can be a challenge because many symptoms are similar to other conditions. Borrelia burgdorferi antibody tests such as the Wampole PreVue assay are a critical component in diagnosing Lyme disease. Wampole Laboratories is a market leader in Lyme disease testing and the PreVue B. burgdorferi test expands their presence into the point-of care segment of this market. Wampole is working on the development of additional recombinant-based Lyme tests that will be useful in patients who have been vaccinated against Lyme disease. The work is being done in conjunction with scientists at Brook Biotechnologies and SUNY Stony Brook, where the PreVue B. burgdorferi product's core technology was developed. CONTACT: Wampole Labs, Cranbury P. Zych Vice President of Marketing 609/655-6587 To edit your profile, go to keyword <A HREF= " aol://1722:NewsProfiles " >NewsProfiles </A>. For all of today's news, go to keyword <A HREF= " aol://1722:News " >News</A> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 1999 Report Share Posted June 22, 1999 this is old news....came out about 4 months ago.....they claimed a 90% accuracy rate.......if regular testing is only 30% how will a " fast test " be any better??????? Reid Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 1999 Report Share Posted June 22, 1999 In a message dated 6/22/1999 2:41:21 PM Eastern Daylight Time, RMcmur3194@... writes: << .came out about 4 months ago. >> Reid: Check your info......I don't think this is the same test. Mona Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 1999 Report Share Posted June 22, 1999 same test same co....was in the paper 4 months ago also on the web.......i will double check though.......still a quick test when they can't sdo it right by taking time....???????guess i am skeptical by nature....... Reid Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 1999 Report Share Posted June 22, 1999 What test is this? My ISP has been down and I'm not getting all ofthe posts - can someone tell me who is the company , a way to contact them and what is the name of the test???? Is it really that much more accurate ???? Jaqui Re: [ ] New Rapid Lyme test >From: RMcmur3194@... > >this is old news....came out about 4 months ago.....they claimed a 90% >accuracy rate.......if regular testing is only 30% how will a " fast test " be >any better??????? >Reid > >--------------------------- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.